197 related articles for article (PubMed ID: 15331017)
1. No evidence for involvement of SDHD in neuroblastoma pathogenesis.
De Preter K; Vandesompele J; Hoebeeck J; Vandenbroecke C; Smet J; Nuyts A; Laureys G; Combaret V; Van Roy N; Roels F; Van Coster R; Praet M; De Paepe A; Speleman F
BMC Cancer; 2004 Aug; 4():55. PubMed ID: 15331017
[TBL] [Abstract][Full Text] [Related]
2. CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23.
Michels E; Hoebeeck J; De Preter K; Schramm A; Brichard B; De Paepe A; Eggert A; Laureys G; Vandesompele J; Speleman F
BMC Cancer; 2008 Jun; 8():173. PubMed ID: 18559103
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
[TBL] [Abstract][Full Text] [Related]
4. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
[TBL] [Abstract][Full Text] [Related]
5. LOH on chromosome 11q, but not SDHD and Men1 mutations was frequently detectable in Chinese patients with pheochromocytoma and paraganglioma.
Sun HY; Cui B; Su DW; Jin XL; Sun FK; Zu Y; Jiang L; Wang WQ; Ning G
Endocrine; 2006 Dec; 30(3):307-12. PubMed ID: 17526943
[TBL] [Abstract][Full Text] [Related]
6. Disomy as the genetic underlying mechanisms of loss of heterozigosity in SDHD-paragangliomas.
Beristain E; Vicente MA; Guerra I; Gutiérrez-Corres FB; Garin I; Perez de Nanclares G
J Clin Endocrinol Metab; 2013 May; 98(5):E1012-6. PubMed ID: 23493432
[TBL] [Abstract][Full Text] [Related]
7. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
[TBL] [Abstract][Full Text] [Related]
8. Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas.
Hoekstra AS; Hensen EF; Jordanova ES; Korpershoek E; van der Horst-Schrivers AN; Cornelisse C; Corssmit EP; Hes FJ; Jansen JC; Kunst HP; Timmers HJ; Bateman A; Eccles D; Bovée JV; Devilee P; Bayley JP
Oncotarget; 2017 Feb; 8(9):14525-14536. PubMed ID: 28099933
[TBL] [Abstract][Full Text] [Related]
9. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.
Gimenez-Roqueplo AP; Favier J; Rustin P; Mourad JJ; Plouin PF; Corvol P; Rötig A; Jeunemaitre X
Am J Hum Genet; 2001 Dec; 69(6):1186-97. PubMed ID: 11605159
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma.
Astuti D; Morris M; Krona C; Abel F; Gentle D; Martinsson T; Kogner P; Neumann HP; Voutilainen R; Eng C; Rustin P; Latif F; Maher ER
Br J Cancer; 2004 Nov; 91(10):1835-41. PubMed ID: 15505628
[TBL] [Abstract][Full Text] [Related]
11. Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss.
Badenhop RF; Cherian S; Lord RS; Baysal BE; Taschner PE; Schofield PR
Genes Chromosomes Cancer; 2001 Jul; 31(3):255-63. PubMed ID: 11391796
[TBL] [Abstract][Full Text] [Related]
12. Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier in SDHD-linked paragangliomas: SLC22A18 and CDKN1C are candidate tumour modifiers.
Hoekstra AS; Addie RD; Ras C; Seifar RM; Ruivenkamp CA; Briaire-de Bruijn IH; Hes FJ; Jansen JC; Corssmit EP; Corver WE; Morreau H; Bovée JV; Bayley JP; Devilee P
Hum Mol Genet; 2016 Sep; 25(17):3715-3728. PubMed ID: 27402879
[TBL] [Abstract][Full Text] [Related]
13. Genomic structure and mutational analysis of the human KIF1B gene which is homozygously deleted in neuroblastoma at chromosome 1p36.2.
Yang HW; Chen YZ; Takita J; Soeda E; Piao HY; Hayashi Y
Oncogene; 2001 Aug; 20(36):5075-83. PubMed ID: 11526494
[TBL] [Abstract][Full Text] [Related]
14. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.
Guo C; White PS; Weiss MJ; Hogarty MD; Thompson PM; Stram DO; Gerbing R; Matthay KK; Seeger RC; Brodeur GM; Maris JM
Oncogene; 1999 Sep; 18(35):4948-57. PubMed ID: 10490829
[TBL] [Abstract][Full Text] [Related]
15. A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region.
Baysal BE; Willett-Brozick JE; Taschner PE; Dauwerse JG; Devilee P; Devlin B
Eur J Hum Genet; 2001 Feb; 9(2):121-9. PubMed ID: 11313745
[TBL] [Abstract][Full Text] [Related]
16. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families.
Hensen EF; Jordanova ES; van Minderhout IJ; Hogendoorn PC; Taschner PE; van der Mey AG; Devilee P; Cornelisse CJ
Oncogene; 2004 May; 23(23):4076-83. PubMed ID: 15064708
[TBL] [Abstract][Full Text] [Related]
17. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
Ejeskär K; Krona C; Carén H; Zaibak F; Li L; Martinsson T; Ioannou PA
BMC Cancer; 2005 Dec; 5():161. PubMed ID: 16359544
[TBL] [Abstract][Full Text] [Related]
18. Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma.
Burnichon N; Mazzella JM; Drui D; Amar L; Bertherat J; Coupier I; Delemer B; Guilhem I; Herman P; Kerlan V; Tabarin A; Wion N; Lahlou-Laforet K; Favier J; Gimenez-Roqueplo AP
J Med Genet; 2017 Feb; 54(2):125-133. PubMed ID: 27856506
[TBL] [Abstract][Full Text] [Related]
19. A conditional mouse mutant in the tumor suppressor SdhD gene unveils a link between p21(WAF1/Cip1) induction and mitochondrial dysfunction.
Millán-Uclés A; Díaz-Castro B; García-Flores P; Báez A; Pérez-Simón JA; López-Barneo J; Piruat JI
PLoS One; 2014; 9(1):e85528. PubMed ID: 24465590
[TBL] [Abstract][Full Text] [Related]
20. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma.
Gimm O; Armanios M; Dziema H; Neumann HP; Eng C
Cancer Res; 2000 Dec; 60(24):6822-5. PubMed ID: 11156372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
